ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 229 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q1 2019. The put-call ratio across all filers is 1.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $119,325,120 | +4.8% | 9,080,923 | +0.5% | 0.04% | +8.3% |
Q2 2023 | $113,840,341 | -4.3% | 9,035,018 | -0.9% | 0.04% | -10.0% |
Q1 2023 | $118,923,332 | +72567.5% | 9,112,956 | -1.8% | 0.04% | -16.7% |
Q4 2022 | $163,654 | -99.9% | 9,277,320 | +0.1% | 0.05% | -11.1% |
Q3 2022 | $141,126,000 | +1.5% | 9,266,239 | -1.1% | 0.05% | +8.0% |
Q2 2022 | $138,997,000 | -36.2% | 9,372,570 | -3.2% | 0.05% | -25.4% |
Q1 2022 | $218,017,000 | +17.1% | 9,681,082 | -4.1% | 0.07% | +19.6% |
Q4 2021 | $186,161,000 | +30.4% | 10,090,059 | -5.5% | 0.06% | +21.7% |
Q3 2021 | $142,786,000 | -29.9% | 10,679,522 | -3.0% | 0.05% | -29.2% |
Q2 2021 | $203,753,000 | +23.4% | 11,007,649 | +0.0% | 0.06% | +18.2% |
Q1 2021 | $165,050,000 | +4.5% | 11,003,259 | +0.6% | 0.06% | -3.5% |
Q4 2020 | $157,966,000 | +74.4% | 10,939,535 | -1.7% | 0.06% | +50.0% |
Q3 2020 | $90,584,000 | +20.5% | 11,128,411 | +0.2% | 0.04% | +15.2% |
Q2 2020 | $75,151,000 | -2.8% | 11,101,009 | +1.1% | 0.03% | -17.5% |
Q1 2020 | $77,289,000 | -24.0% | 10,978,362 | +6.0% | 0.04% | +8.1% |
Q4 2019 | $101,680,000 | -7.7% | 10,359,633 | +3.3% | 0.04% | -14.0% |
Q3 2019 | $110,154,000 | -3.4% | 10,032,508 | +2.3% | 0.04% | -2.3% |
Q2 2019 | $114,044,000 | +29.1% | 9,806,183 | +5.9% | 0.04% | +25.7% |
Q1 2019 | $88,352,000 | -6.2% | 9,261,017 | -5.3% | 0.04% | -18.6% |
Q4 2018 | $94,242,000 | -34.3% | 9,776,274 | -2.9% | 0.04% | -21.8% |
Q3 2018 | $143,492,000 | +14.5% | 10,069,678 | -3.6% | 0.06% | +10.0% |
Q2 2018 | $125,347,000 | +0.7% | 10,445,549 | +3.6% | 0.05% | -3.8% |
Q1 2018 | $124,469,000 | -14.9% | 10,078,477 | +0.2% | 0.05% | -14.8% |
Q4 2017 | $146,344,000 | +8.2% | 10,057,962 | +5.8% | 0.06% | +3.4% |
Q3 2017 | $135,308,000 | +15.6% | 9,508,667 | +3.7% | 0.06% | +9.3% |
Q2 2017 | $117,026,000 | +27.7% | 9,171,285 | +26.9% | 0.05% | +22.7% |
Q1 2017 | $91,648,000 | +35.9% | 7,227,789 | +9.4% | 0.04% | +29.4% |
Q4 2016 | $67,451,000 | -18.2% | 6,606,169 | +5.5% | 0.03% | -24.4% |
Q3 2016 | $82,478,000 | +18.0% | 6,262,725 | +13.8% | 0.04% | +12.5% |
Q2 2016 | $69,893,000 | -19.5% | 5,503,510 | -16.3% | 0.04% | -23.1% |
Q1 2016 | $86,854,000 | -14.5% | 6,574,954 | -0.4% | 0.05% | -17.5% |
Q4 2015 | $101,530,000 | +21.8% | 6,601,437 | -1.8% | 0.06% | +14.5% |
Q3 2015 | $83,327,000 | -0.5% | 6,719,981 | +9.8% | 0.06% | +7.8% |
Q2 2015 | $83,734,000 | +38.6% | 6,120,655 | +21.2% | 0.05% | +34.2% |
Q1 2015 | $60,395,000 | +56.8% | 5,049,882 | +67.4% | 0.04% | +52.0% |
Q4 2014 | $38,527,000 | -4.8% | 3,016,903 | -0.0% | 0.02% | -13.8% |
Q3 2014 | $40,479,000 | -16.3% | 3,017,347 | +0.2% | 0.03% | -14.7% |
Q2 2014 | $48,355,000 | -2.8% | 3,012,732 | +9.2% | 0.03% | -8.1% |
Q1 2014 | $49,726,000 | +17.8% | 2,757,828 | +1.0% | 0.04% | +12.1% |
Q4 2013 | $42,205,000 | +27.0% | 2,729,995 | +22.1% | 0.03% | +13.8% |
Q3 2013 | $33,244,000 | +23.5% | 2,235,676 | +7.4% | 0.03% | +16.0% |
Q2 2013 | $26,929,000 | – | 2,080,896 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |